Tsun-Mei Lin Selected Research

Tsun-Mei Lin Research Topics

Disease

9	Infections 04/2014 - 01/2002
4	Biliary Atresia 10/2012 - 08/2005
3	Stroke (Strokes) 11/2021 - 08/2003
3	Peritoneal Fibrosis 01/2021 - 01/2015
3	Neoplasms (Cancer) 04/2019 - 03/2002
2	Chronic Renal Insufficiency 01/2021 - 01/2021
2	Vascular Calcification 01/2021 - 01/2019
2	Hypercalcemia (Milk Alkali Syndrome) 01/2021 - 01/2019
2	Carcinoma (Carcinomatosis) 04/2019 - 03/2002
2	Inflammation (Inflammations) 02/2014 - 11/2007
2	Cholestasis 01/2012 - 08/2005
2	Papillomavirus Infections 06/2009 - 03/2002
1	Coronary Disease (Coronary Heart Disease) 11/2021
1	Uremia 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Breast Neoplasms (Breast Cancer) 02/2019
1	Fibrosis (Cirrhosis) 01/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2014
1	Peritonitis 02/2014
1	Lymphadenitis (Adenitis) 09/2013
1	Carcinogenesis 04/2013
1	Hepatocellular Carcinoma (Hepatoma) 04/2013
1	Obstructive Jaundice (Cholestatic Jaundice) 10/2012
1	Insulin Resistance 01/2012
1	Rheumatoid Arthritis 01/2012
1	Jaundice (Icterus) 12/2010
1	Choledochal Cyst (Choledochal Cysts) 12/2010
1	Neointima 03/2009
1	Virus Diseases (Viral Diseases) 11/2007
1	Liver Cirrhosis (Hepatic Cirrhosis) 08/2005
1	Factor V Deficiency 03/2005
1	Ischemic Stroke 08/2003
1	Papilloma (Papillomatosis) 03/2002

Drug/Important Bio-Agent (IBA)

3	Vitamin D FDA LinkGeneric 01/2021 - 01/2015
3	CytokinesIBA 02/2019 - 04/2002
3	EndotoxinsIBA 01/2012 - 08/2005
2	ImmunosorbentsIBA 02/2019 - 12/2010
2	EnzymesIBA 02/2019 - 12/2010
2	Dialysis SolutionsIBA 01/2015 - 02/2014
2	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 09/2013 - 06/2009
2	Toll-Like Receptor 7IBA 04/2013 - 10/2012
2	Lipopolysaccharide ReceptorsIBA 12/2010 - 08/2005
2	LipidsIBA 08/2003 - 04/2002
1	Metalloproteases (Metalloproteinases)IBA 11/2021
1	DisintegrinsIBA 11/2021
1	InflammasomesIBA 01/2021
1	IndicanIBA 01/2021
1	MagnesiumIBA 01/2021
1	Cholecalciferol (Vitamin D3)FDA Link 01/2021
1	Therapeutic UsesIBA 01/2021
1	CortactinIBA 04/2019
1	Biomarkers (Surrogate Marker)IBA 04/2019
1	Zoledronic Acid (Zometa)FDA Link 02/2019
1	Conditioned Culture MediaIBA 02/2019
1	hydroxide ionIBA 01/2015
1	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 01/2015
1	HLA Antigens (Human Leukocyte Antigens)IBA 06/2014
1	AntibodiesIBA 06/2014
1	Toll-Like Receptor 8IBA 04/2014
1	InterferonsIBA 04/2013
1	salicylhydroxamic acid (SHAM)IBA 10/2012
1	Toll-Like Receptor 2IBA 01/2012
1	Peptidoglycan (Murein)IBA 01/2012
1	Becaplermin (PDGF-BB)FDA Link 03/2009
1	Interleukin-4 (Interleukin 4)IBA 01/2009
1	Chaperonin 60IBA 10/2008
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2007
1	endotoxin receptorIBA 08/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2005
1	Recombinant ProteinsIBA 03/2005
1	Factor V (Coagulation Factor V)IBA 03/2005
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2004
1	Mitogen-Activated Protein KinasesIBA 07/2004
1	Plasminogen Activator Inhibitor 1IBA 08/2003
1	Plasminogen Activators (Plasminogen Activator)IBA 08/2003
1	Formaldehyde (Formol)FDA Link 03/2002
1	DNA (Deoxyribonucleic Acid)IBA 03/2002
1	ParaffinIBA 03/2002
1	Mannose ReceptorIBA 01/2002

Therapy/Procedure

4	Peritoneal Dialysis 01/2021 - 06/2014
2	Renal Dialysis (Hemodialysis) 01/2021 - 06/2014
2	Ligation 10/2012 - 03/2009
1	Therapeutics 11/2016
1	Immunomodulation 11/2016
1	Intraperitoneal Injections 01/2015
1	Liver Transplantation 12/2010
1	Hepatic Portoenterostomy 12/2010